Harvard Bioscience Inc (HBIO) SEC Filings — 2025
18 SEC filings for Harvard Bioscience Inc (HBIO) in 2025.
Filings
- Harvard Bioscience Inc 8-K Filing — 8-K · Dec 17, 2025
- Harvard Bioscience Files 8-K Report — 8-K · Dec 5, 2025
- Harvard Bioscience Plunges into Deeper Loss Amidst Goodwill Impairment — 10-Q · Nov 6, 2025
- Harvard Bioscience Faces Delisting Concerns — 8-K · Oct 3, 2025
- Harvard Bioscience Announces Board Changes and Officer Appointments — 8-K · Sep 9, 2025
- Harvard Bioscience Announces Board and Executive Changes — 8-K · Aug 13, 2025
- Harvard Bioscience Swings to Loss Amid Rising Costs — 10-Q · Aug 11, 2025
- Harvard Bioscience Files 8-K on Officer/Director Changes — 8-K · Jul 17, 2025
- Harvard Bioscience Files 8-K/A Amendment on Delisting Concerns — 8-K/A · Jun 27, 2025
- Harvard Bioscience Faces Delisting Concerns — 8-K · Jun 23, 2025
- Harvard Bioscience Announces Board and Executive Compensation Changes — 8-K · Jun 13, 2025
- Harvard Bioscience Files 8-K on Officer Changes and Shareholder Votes — 8-K · Jun 2, 2025
- Harvard Bioscience Q1 2025 10-Q Filed — 10-Q · May 12, 2025
- Harvard Bioscience Files 2025 Proxy Statement — DEF 14A · Apr 21, 2025
- Harvard Bioscience Files 8-K on Officer/Director Changes — 8-K · Apr 16, 2025
- Harvard Bioscience Faces Nasdaq Delisting Notice — 8-K · Apr 10, 2025
- Harvard Bioscience Files 2024 10-K — 10-K · Mar 14, 2025
- Harvard Bioscience Files 8-K: Material Agreement, Other Events — 8-K · Mar 12, 2025